Institute for Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Institute for Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.2K	Buy	+479	New	+$15.3K	﹤0.01%	1130

Other funds holding ARKG

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $1.02B AUM 31.16% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

MFPI

Midwest Financial Partners Investments St. Cloud, Minnesota $241M AUM

CIC

Canal Insurance Company Greenville, South Carolina $456M AUM 40.11% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Institute for Wealth Management's ARKG Position: Q2 2026 in Review

Institute for Wealth Management opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 479 shares worth $20.2K. The stake represents ﹤0.01% of the portfolio and ranks #1130 among its holdings.

169 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

Institute for Wealth Management held 479 shares of ARK Genomic Revolution ETF worth $20.2K as of Q2 2026.
ARK Genomic Revolution ETF was a new Institute for Wealth Management position in Q2 2026.
ARK Genomic Revolution ETF made up ﹤0.01% of Institute for Wealth Management's portfolio in Q2 2026, its #1130 holding.
169 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Institute for Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.